Our Team

Our team is uniquely positioned to execute our mission of translating our deep understanding of cellular metabolism into medicines that improve the lives of patients with limited or inadequate treatment options.

Alvin Shih
Executive Chair
Nikola Trbovic
Board Observer
Jai Patel
Chief Medical Officer
Komal Joshi
Chief Financial Officer
Arash Yavari
Chief Scientific Officer
Sarb Shergill
Senior Vice President, Clinical Development
Karen Jauregui
Senior Vice President, Regulatory Affairs, Quality and CMC
Vanessa Murray
Director, Clinical Operations
Marcus Hansen
Director, CMC API

You Are About to Leave Imbria Pharmaceuticals

The appearance of external hyperlinks does not constitute endorsement by Imbria Pharmaceuticals of the linked websites, or the information, products or services contained therein.

URL: